Sponsor study identifier
interventional
52
1 country
1
Study Start
September 9, 2022
Actual (reported)Primary Completion
December 16, 2022
Actual (reported)Study Completion
December 23, 2022
Actual (reported)The aim of this study is to compare and evaluate the analgesic effects of ultrasound-guided Erector Spinae Plane block using low volumes and high concentrations versus high volumes and low concentrations in patients undergoing MRM.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 23, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 9, 2022
Actual (reported)November 18, 2022
Actual (reported)December 16, 2022
Actual (reported)December 23, 2022
Actual (reported)April 14, 2023
Actual (reported)Total dose of morphine needed postoperatively
Total dose of morphine needed postoperatively
Through Study Completion Up to 1 Day
Time to first rescue analgesia, starting after extubation
Through Study Completion over the first 24 hours postoperative
Duration of surgery
Through Study Completion 24 hours postoperative
Blood loss,
Through Study Completion,an average of 1day
Total dose of fentanyl required intraoperative (including induction dose)
Through study completion,an average of 1day
Pain score at 15, 30, 45 and 60 min., 3,6,12 and 24 h after surgery
through study completion,an average of 1day
Patients will preoperatively receive low concentration-high volume U/S ESP block, and then the patient will be transferred to the operating room one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline}, for each patient.
Patients will preoperatively receive high concentration-low volume U/S ESP block block, and then the patient will be transferred to the operating room one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% }, for each patien).
Patients will preoperatively receive low concentration-high volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline} for each patient
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
Ahmed Abdalla Mohamed, M.D
Cairo University
52 participants (actual enrollment reported by the registry).
First Submitted
November 18, 2022
First Posted
Patients will preoperatively receive high concentration-low volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% } for each patien).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
April 14, 2023
Study Start
September 9, 2022
Actual (reported)Primary Completion
December 16, 2022
Actual (reported)Study Completion
December 23, 2022
Actual (reported)Last Updated
May 3, 2023
Record last verified: 2023-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: